BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20581766)

  • 1. Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era.
    Briceño J; Ciria R; de la Mata M; Rufián S; López-Cillero P
    Transplantation; 2010 Sep; 90(5):530-9. PubMed ID: 20581766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient?
    Maluf DG; Edwards EB; Kauffman HM
    Transplantation; 2006 Dec; 82(12):1653-7. PubMed ID: 17198254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.
    Silberhumer GR; Pokorny H; Hetz H; Herkner H; Rasoul-Rockenschaub S; Soliman T; Wekerle T; Berlakovich GA; Steininger R; Muehlbacher F
    Transplantation; 2007 Mar; 83(5):588-92. PubMed ID: 17353779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor liver dysfunction: application of a new scoring system to identify the marginal donor.
    Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Fonseca LE; Motta TD; Pandullo FL; Rezende MB; Meira-Filho SP; Sá JR; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2516-8. PubMed ID: 17954162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MELD and prediction of post-liver transplantation survival.
    Habib S; Berk B; Chang CC; Demetris AJ; Fontes P; Dvorchik I; Eghtesad B; Marcos A; Shakil AO
    Liver Transpl; 2006 Mar; 12(3):440-7. PubMed ID: 16498643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assignment of steatotic livers by the Mayo model for end-stage liver disease.
    Briceño J; Padillo J; Rufián S; Solórzano G; Pera C
    Transpl Int; 2005 May; 18(5):577-83. PubMed ID: 15819807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor age and cold ischemia interact to produce inferior 90-day liver allograft survival.
    Reese PP; Sonawane SB; Thomasson A; Yeh H; Markmann JF
    Transplantation; 2008 Jun; 85(12):1737-44. PubMed ID: 18580465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis.
    Segev DL; Nguyen GC; Locke JE; Simpkins CE; Montgomery RA; Maley WR; Thuluvath PJ
    Liver Transpl; 2007 Sep; 13(9):1285-94. PubMed ID: 17763380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD
    Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of marginal donors to liver transplantation for hepatitis C virus infection.
    Briceño J; Ciria R; Pleguezuelo M; Naranjo A; Sánchez-Hidalgo J; Ruiz-Rabelo J; López-Cillero P; Luque A; de la Mata M; Rufián S
    Transplant Proc; 2007 Sep; 39(7):2297-9. PubMed ID: 17889169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.
    Santori G; Andorno E; Morelli N; Antonucci A; Bottino G; Mondello R; Castiglione AG; Valente R; Ravazzoni F; Di Domenico S; Valente U
    Transpl Int; 2005 Jan; 18(1):65-72. PubMed ID: 15612986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using elderly donors in liver transplantation.
    Grazi GL; Ravaioli M; Zanello M; Ercolani G; Cescon M; Varotti G; Del Gaudio M; Vetrone G; Lauro A; Ramacciato G; Pinna AD
    Transplant Proc; 2005; 37(6):2582-3. PubMed ID: 16182750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live donor liver transplantation in high MELD score recipients.
    Selzner M; Kashfi A; Cattral MS; Selzner N; McGilvray ID; Greig PD; Levy GA; Renner EL; Grant DR
    Ann Surg; 2010 Jan; 251(1):153-7. PubMed ID: 19858705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.
    Kim JD; Choi JY; Kwon JH; Jang JW; Bae SH; Yoon SK; You YK; Kim DG
    Transplant Proc; 2009 Nov; 41(9):3766-8. PubMed ID: 19917383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.
    Desai NM; Mange KC; Crawford MD; Abt PL; Frank AM; Markmann JW; Velidedeoglu E; Chapman WC; Markmann JF
    Transplantation; 2004 Jan; 77(1):99-106. PubMed ID: 14724442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.